KZR-504 |
Covalent Inhibitor of PSMB9
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PSMB9 |
|
|
Covalent Inhibitor
300 nM - 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - Beta1, MECL1, Beta2: >250 uM, LMP7, Beta5: >6 uM
Potency Assay Off-Target:
In a MOLT-4 (human T cell leukemia) cellular lysate, a proteasome constitutive/immunoproteasome subu ...
In Cell Selectivity Assessment
Potency: IC50
Potency Assay Off-Target:
Utilizing MOLT-4 (human T cell leukemia) whole (live) cells, a proteasome constitutive/immunoproteas ...
Potency Cellular
In Vitro
PSMB9
Mode of Action: Covalent Inhibitor
Structure-Activity-Relationship data available? No
In Vivo Validations
Female BALBc mice
Dose: 1 mg/kg and 30 mg/kg
Route of delivery:
Intravenous
Organ of interest (O):
Blood, Heart, Kidney, Liver, Brain
Target engagement assay:
Target inhibition in tissues was measured by ProCISE. In all tissues except brain, a 1 mg/kg dose yielded target inhibition >50%. In brain, a 30 mg/kg dose yielded target inhibition to 40%.
Reference: --
Chemical Information
| Molecular Formula | C21H23N3O6 |
| SMILEs | C[C@]1(C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)c2cccc(=O)[nH]2)CO1 |
| InChI | InChI=1S/C21H23N3O6/c1-21(12-30-21)18(27)15(10-13-6-3-2-4-7-13)23-20(29)16(11-25)24-19(28)14-8-5-9-17(26)22-14/h2-9,15-16,25H,10-12H2,1H3,(H,22,26)(H,23,29)(H,24,28)/t15-,16-,21+/m0/s1 |
| Molecular weight | 413.16 Da |
| AlogP | -0.4488999999999992 |
| HBond acceptors | 9 |
| HBond donors | 4 |
| Atoms | 53 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.